The Family Firm’s CEL-SCI Corp CVM Stock Holding History

The Family Firm’s Portfolio CVM Stock Details CVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6	Closed	-$196	–	347
2024 Q2	$196	Buy	+6	New	+$256	﹤0.01%	872

Other funds holding CVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TFS

Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

The Family Firm's CVM Position: Q3 2024 in Review

The Family Firm sold out of CEL-SCI Corp (CVM) in Q3 2024, closing a stake of 6 shares — an estimated $196 sold.

The Family Firm first reported a position in CVM in Q2 2024 and held it in 1 quarter. The position peaked at $196 in Q2 2024. 64 funds tracked by Wall St. Rank hold CVM as of Q3 2024.

The Family Firm reported no remaining CEL-SCI Corp position as of Q3 2024 after selling out during the quarter.
The Family Firm sold 6 CEL-SCI Corp shares in Q3 2024, an estimated $196.
The Family Firm first reported a position in CEL-SCI Corp in Q2 2024 and held it in 1 quarter.
The Family Firm's CEL-SCI Corp position peaked at $196 in Q2 2024.
64 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.